全文获取类型
收费全文 | 78815篇 |
免费 | 5750篇 |
国内免费 | 2698篇 |
专业分类
耳鼻咽喉 | 549篇 |
儿科学 | 1125篇 |
妇产科学 | 1114篇 |
基础医学 | 13846篇 |
口腔科学 | 1225篇 |
临床医学 | 4440篇 |
内科学 | 11643篇 |
皮肤病学 | 1250篇 |
神经病学 | 12114篇 |
特种医学 | 1058篇 |
外国民族医学 | 19篇 |
外科学 | 4573篇 |
综合类 | 8603篇 |
现状与发展 | 8篇 |
一般理论 | 2篇 |
预防医学 | 2637篇 |
眼科学 | 1125篇 |
药学 | 13429篇 |
5篇 | |
中国医学 | 2189篇 |
肿瘤学 | 6309篇 |
出版年
2024年 | 105篇 |
2023年 | 897篇 |
2022年 | 1282篇 |
2021年 | 2508篇 |
2020年 | 2106篇 |
2019年 | 2113篇 |
2018年 | 2236篇 |
2017年 | 2313篇 |
2016年 | 2382篇 |
2015年 | 2723篇 |
2014年 | 4404篇 |
2013年 | 5761篇 |
2012年 | 4311篇 |
2011年 | 4978篇 |
2010年 | 4094篇 |
2009年 | 4264篇 |
2008年 | 4496篇 |
2007年 | 4106篇 |
2006年 | 3571篇 |
2005年 | 3081篇 |
2004年 | 2868篇 |
2003年 | 2637篇 |
2002年 | 2141篇 |
2001年 | 1823篇 |
2000年 | 1650篇 |
1999年 | 1447篇 |
1998年 | 1600篇 |
1997年 | 1507篇 |
1996年 | 1386篇 |
1995年 | 1093篇 |
1994年 | 1009篇 |
1993年 | 912篇 |
1992年 | 701篇 |
1991年 | 663篇 |
1990年 | 508篇 |
1989年 | 451篇 |
1988年 | 379篇 |
1987年 | 330篇 |
1986年 | 358篇 |
1985年 | 418篇 |
1984年 | 347篇 |
1983年 | 212篇 |
1982年 | 276篇 |
1981年 | 244篇 |
1980年 | 171篇 |
1979年 | 107篇 |
1978年 | 81篇 |
1977年 | 64篇 |
1976年 | 46篇 |
1975年 | 44篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
61.
S. Xing X. Zhang J. H. Liu X. Huang P. Zhou 《Clinical and experimental immunology》2019,195(1):121-131
Recent experimental strategies to reduce graft-versus-host disease (GVHD) have focused largely on modifying innate immunity. Toll-like receptor (TLR)-driven myeloid differentiation primary response 88 (MyD88)-dependent signalling pathways that initiate adaptive immune function are also critical for the pathogenesis of GVHD. This study aimed to delineate the role of host MyD88 in the development of acute GVHD following fully major histocompatibility complex-mismatched allogeneic bone marrow transplantation (BMT). When myeloablated BALB/c MyD88 knock-out recipients were transplanted with C57BL/6 (B6) donor cells, they developed significantly more severe GVHD than wild-type (WT) BALB/c hosts. The increased morbidity and mortality in MyD88–/– mice correlated with increased serum levels of lipopolysaccharide and elevated inflammatory cytokines in GVHD target organs. Additionally, MyD88 deficiency in BMT recipients led to increased donor T cell expansion and more donor CD11c+ cell intestinal infiltration with apoptotic cells but reduced proliferation of intestinal epithelial cells compared with that in WT BMT recipients. Decreased expression of tight junction mRNA in epithelial cells of MyD88–/– mice suggested that MyD88 contributes to intestinal integrity. Cox-2 expression in the GVHD-targeted organs of WT mice is increased upon GVHD induction, but this enhanced expression was obviously inhibited by MyD88 deficiency. The present findings demonstrate an unexpected role for host MyD88 in preventing GVHD after allogeneic BMT. 相似文献
62.
63.
目的:探讨红景天苷(salidroside,SAL)对树突状细胞(dendritic cell,DC)表型及细胞毒性T细胞(cytotoxic T lympho‐cyte,CTL)抗肿瘤能力的影响。方法:选用Lewis肺癌细胞株3LL、野生型C57BL/6和TLR4-/-C57BL/6小鼠,获取小鼠骨髓来源的DC前体细胞,经过培养分化成未成熟DC,收获第6天的DC,经磁珠分选后获得纯度较高的CD11c+DC。将细胞分成PBS组、SAL组和脂多糖(lipopolysaccharide,LPS)组,培养48 h后用流式细胞术检测SAL体外对DC表面分子、吞噬功能、TLR4通路和对T细胞杀伤能力的影响。结果:与 PBS 组比较,SAL组DC的表面分子CD80、CD86、MHC Ⅱ表达水平显著升高(均 P<0.05)、吞噬功能显著下降(P<0.05)、TLR4 表达水平显著升高(P<0.01);与野生型组比较,TLR4-/-组DC经SAL或LPS处理后,其表面分子CD80、CD86、MHC Ⅱ的表达水平显著降低(均P<0.05);与PBS组比较,SAL组刺激活化的CTL对肺癌3LL细胞的杀伤效应显著升高(P<0.05)。结论:SAL可以通过调控TLR4诱导DC成熟,从而提高T细胞的杀伤能力 相似文献
64.
《Vaccine》2020,38(39):6141-6152
Influenza vaccination is considered the most valuable means to prevent and control seasonal influenza infections, which causes various clinical symptoms, ranging from mild cough and fever to even death. Among various influenza vaccine types, the inactivated subunit type is known to provide improved safety with reduced reactogenicity. However, there are some drawbacks associated with inactivated subunit type vaccines, with the main ones being its low immunogenicity and the induction of Th2-biased immune responses. In this study, we investigated the role of a single-stranded RNA (ssRNA) derived from the intergenic region in the internal ribosome entry site of the Cricket paralysis virus as an adjuvant rather than the universal vaccine for a seasonal inactivated subunit influenza vaccine. The ssRNA adjuvant stimulated not only well-balanced cellular (indicated by IgG2a, IFN-γ, IL-2, and TNF-α) and humoral (indicated by IgG1 and IL-4) immune responses but also a mucosal immune response (indicated by IgA), a key protector against respiratory virus infections. It also increases the HI titer, the surrogate marker of influenza vaccine efficacy. Furthermore, ssRNA adjuvant confers cross-protective immune responses against heterologous influenza virus infection while promoting enhanced viral clearance. Moreover, ssRNA adjuvant increases the number of memory CD4+ and CD8+ T cells, which can be expected to induce long-term immune responses. Therefore, this ssRNA-adjuvanted seasonal inactivated subunit influenza vaccine might be the best influenza vaccine generating robust humoral and cellular immune responses and conferring cross-protective and long-term immunity. 相似文献
65.
ABSTRACT Tryptophan (Trp) is not only a nutrient enhancer but also has systemic effects. Trp metabolites signaling through the well-known aryl hydrocarbon receptor (AhR) constitute the interface of microbiome-gut-brain axis. However, the pathway through which Trp metabolites affect central nervous system (CNS) function have not been fully elucidated. AhR participates in a broad variety of physiological and pathological processes that also highly relevant to intestinal homeostasis and CNS diseases. Via the AhR-dependent mechanism, Trp metabolites connect bidirectional signaling between the gut microbiome and the brain, mediated via immune, metabolic, and neural (vagal) signaling mechanisms, with downstream effects on behavior and CNS function. These findings shed light on the complex Trp regulation of microbiome-gut-brain axis and add another facet to our understanding that dietary Trp is expected to be a promising noninvasive approach for alleviating systemic diseases. 相似文献
66.
《Journal of thoracic oncology》2021,16(9):1449-1460
Pulmonary immune-related adverse events represent rare but potentially severe side effects of immunotherapies. Diagnosis is often challenging, as symptoms and imaging features are not specific and may mimic other lung diseases, thus potentially delaying appropriate patient management. In this setting, an accurate imaging evaluation is essential for a prompt detection and correct management of these drug-induced lung diseases. The purpose of this article is to review the different types of pulmonary immune-related adverse events, describe their imaging characteristics on both high-resolution computed tomography and positron emission tomography/computed tomography and stress their underlying diagnostic challenge by presenting the mimickers. 相似文献
67.
68.
69.
OBJECTIVES: To assess the effectiveness and safety of additional bedtime H2‐receptor antagonists (H2RAs) in suppressing nocturnal gastric acid breakthrough (NAB) via a systematic review. METHODS: Eligible trials were identified by searching the Cochrane Central Register of Controlled Trials (CENTRAL) (Cochrane Library Issue 2, 2004), MEDLINE (January 1966–June 2004), EMBASE (January 1980–June 2004) and CINAHL (January 1982–June 2004). Additional hand‐searching was conducted on the proceedings of correlated conferences, eight important Chinese journals and references of all included trials. All randomized controlled trials evaluating H2RAs for the control of NAB were eligible for inclusion. The systematic review was conducted using methods recommended by The Cochrane Collaboration. RESULTS: Only two randomized crossover studies, comprising 32 participants, met the inclusion criteria. Because the design, dosage and duration of the treatments were different between the studies, it was not possible to conduct meta‐analysis. There were no consistent conclusions found between the two included studies in evaluating H2RAs for the control of NAB. CONCLUSIONS: No implications for practice at this stage can be concluded. Appropriately designed large‐scale randomized controlled trials with long‐term follow up are needed to determine the effects of additional bedtime H2RAs in suppressing NAB. 相似文献
70.
目的探讨谷氨酸是否能够影响腺苷A2A受体对一氧化氮合酶(NOS)活力的调节。方法用1000ng/ml脂多糖(LPS)刺激小胶质细胞,分别加入100nmol/L A2A受体激动剂CGS21680以及不同浓度的谷氨酸(0,1,0,25,0,5mmol/L)干预,观察NOS活力变化。结果LPS诱导NOS活力增高,激活A2A受体可以产生抑制作用;0,25及0.5mmoL/L谷氨酸和A2A受体激动剂同时存在时,NOS活力进一步增高。结论高浓度谷氨酸可逆转腺苷A2A受体激动剂抑制升高NOS活力的作用。 相似文献